-
Consumer Insights
NewMass Affluent Banking in Greater China – Regional Breakdown by Market Trends, Investment Preferences and Competitor Benchmarking
Mass Affluent Banking Market in Greater China Report Overview Emerging affluents and mass affluents make up most of the affluent population in the Greater China region. The population of affluents has been exponential in the last decade in the region. However, the growth is expected to slow down in the upcoming years as the economies mature. Despite low growth, the number of mass affluent customers in the region is exceedingly large, offering a huge market to the financial providers looking...
-
Product Insights
Likelihood of Approval Analysis for Retinitis Pigmentosa (Retinitis)
Overview How likely is it that the drugs in Retinitis Pigmentosa (Retinitis) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinitis Pigmentosa (Retinitis) Overview Retinitis pigmentosa refers to a group of...
-
Product Insights
Likelihood of Approval Analysis for Chronic Kidney Disease (Chronic Renal Failure)
Overview How likely is it that the drugs in Chronic Kidney Disease (Chronic Renal Failure) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chronic Kidney Disease (Chronic Renal Failure) Overview Chronic...
-
Product Insights
Likelihood of Approval Analysis for Growth Disorders
Overview How likely is it that the drugs in Growth Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Growth Disorders Overview Growth disorders are problems that prevent children from developing...
-
Product Insights
Likelihood of Approval Analysis for Hairy Cell Leukemia
Overview How likely is it that the drugs in Hairy Cell Leukemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hairy Cell Leukemia Overview Hairy cell leukemia is a rare, slow-growing...
-
Product Insights
Likelihood of Approval Analysis for Carcinoid Tumor
Overview How likely is it that the drugs in Carcinoid Tumor will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Carcinoid Tumor Overview Carcinoid tumors are slow-growing tumors arising from neuroendocrine cells...
-
Product Insights
Likelihood of Approval Analysis for Cholestasis
Overview How likely is it that the drugs in Cholestasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cholestasis Overview Cholestasis is the slowing or stalling of bile flow from liver....
-
Product Insights
Likelihood of Approval Analysis for Gastroparesis
Overview How likely is it that the drugs in Gastroparesis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gastroparesis Overview Gastroparesis, also called delayed gastric emptying, is a disorder that slows...
-
Sector Analysis
NewUnited Kingdom (UK) Apparel Market Size and Trend Analysis by Category, Retail Channel, Consumer Attitudes, Brands and Forecast to 2028
UK Apparel Market Report Overview The UK apparel market size was valued at GBP60.7 billion in 2023. The market will witness slow growth at a CAGR of more than 1% during 2023-2028 as consumers will retain a cautious approach to spending, while resale channels and capsule wardrobes will also remain popular. The UK apparel market report offers data that showcase the trends in the market and sectors by value and volume. It also reveals the brand leaders by market share...
-
Product Insights
Likelihood of Approval Analysis for Rett Syndrome
Overview How likely is it that the drugs in Rett Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rett Syndrome Overview Rett syndrome is a neurodevelopmental disorder. This is caused...